Changes in the metabolism of the intestinal microbiome during the development of dyslipidemia, atherosclerosis and cardiovascular diseases have been studied in scientific research. Changes in the gut microbiome were studied for lipid metabolism, increased trimethylamine N oxide, short-chain peptides, and cholesterol homeostasis through the enterohepatic circulation. Probiotic use has been shown to increase Lactobacillus and Bifidobacterium species in the gut microbiota and decrease cholesterol, low-density lipoprotein, and triglycerides.
This work is licensed under a Creative Commons Attribution 4.0 International License.